查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951824

基因组编辑工具市场分析及预测（至2035年）：类型、产品类型、服务、技术、应用、最终用户、组件、流程、功能、设备

Genomic Editing Tools Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Functionality, Equipment
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5个工作天内

价格
简介目录

基因组编辑工具市场预计将从2024年的109亿美元成长到2034年的513亿美元，复合年增长率约为20%。基因组编辑工具市场涵盖了能够实现精确DNA修饰的技术，例如CRISPR、TALEN和ZFN。这些工具透过支持基因治疗、作物改良和合成生物学，促进了医学、农业和生物技术领域的进步。市场成长的驱动因素包括对个人化医疗日益增长的需求、研发投入的增加以及监管政策的调整。创新重点在于提高精准度、效率和伦理考量，凸显了基因组编辑在应对全球健康和粮食安全挑战方面的变革性潜力。

基因组编辑工具市场呈现强劲成长势头，这主要得益于生物技术的进步和医疗保健领域应用的不断拓展。 CRISPR技术凭藉其基因编辑的精准性和高效性，成为表现最佳的细分市场；其次是TALEN和ZFN技术，它们为复杂的基因修饰提供了替代解决方案。治疗应用领域占据主导地位，这主要得益于个人化医疗和罕见疾病基因治疗领域的创新。农业应用领域表现排名第二，反映了市场对改良作物性状和永续农业实践日益增长的需求。科研机构和学术机构是重要的贡献者，它们不断探索基因组编辑的新可能性。新型递送系统的开发实现了靶向高效的基因编辑，进一步增强了市场动态。伦理考量和法规结构正在重塑市场格局，凸显了负责任创新的必要性。人工智慧和生物资讯学的融合有望彻底改变基因组编辑领域，并释放新的成长潜力。

市场区隔
类型 CRISPR、TALEN、锌指核酸酶、Meganucleases
产品 试剂、试剂盒、设备和软体
服务 客製化服务、咨询服务、验证服务
科技 基因敲除、基因敲入、基因静默、基因编辑
应用领域 临床应用、科学研究应用、农业应用、工业应用
最终用户 生技公司、製药公司、学术机构、研究机构
成分 DNA模板、引导RNA、核酸酶、修復模板
过程 体内、试管内、离体
功能 基因破坏、基因校正、基因插入
装置 定序仪、转染装置、细胞分选仪

基因组编辑工具市场竞争格局活跃，主要生物技术公司占据显着的市场份额。定价策略不断演变，反映了创新产品的推出和精准医疗需求的日益增长。频繁的新产品发布凸显了CRISPR技术和其他基因编辑平台的快速发展。在技​​术进步和研究经费增加的推动下，市场正朝着更具成本效益和效率的解决方案转型。基因组编辑工具领域的竞争异常激烈，多家主要企业透过策略联盟和收购争夺主导。法规结构，尤其是在北美和欧洲，在塑造市场动态发挥关键作用。这些法规确保了伦理标准和安全性，并影响技术应用的速度。由于遗传疾病的增加以及基因组编辑在农业和治疗领域的应用不断扩展，市场呈现成长迹象。持续的技术创新和合规性对于保持竞争优势和促进市场扩张仍然至关重要。

主要趋势和驱动因素：

受CRISPR技术进步和研发投入增加的推动，基因组编辑工具市场正经历强劲成长。一个关键趋势是将人工智慧和机器学习结合，以提高基因编辑的精确度和效率。这种技术协同作用正在简化研发流程并缩短研发週期。此外，随着医疗保健向个人化治疗方案转变，个人化医疗的兴起正在推动对基因组编辑工具的需求。农业领域也是一个重要的驱动因素，基因组编辑工具正被用于培育更具抗逆性和环境胁迫性的作物。在面临气候变迁挑战的地区，这趋势尤其明显。此外，监管支持和政府对生物技术研究的资助也在推动市场成长。新兴市场生物技术基础设施的快速发展为众多机会提供了可能，吸引投资并鼓励创新。此外，伦理和安全的考量正在塑造市场格局，促使企业投资开发更安全、更精确的编辑技术。随着公众意识和接受度的提高，基因组编辑工具的潜在应用范围正在扩大，涵盖医疗保健和农业以外的许多行业。在技​​术不断进步和跨学科合作日益密切的推动下，市场有望持续成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • CRISPR
    • TALENs
    • 锌指核酸酶
    • Meganucleases
  • 市场规模及预测：依产品划分
    • 试剂
    • 成套工具
    • 装置
    • 软体
  • 市场规模及预测：依服务划分
    • 客户服务
    • 咨询服务
    • 检验服务
  • 市场规模及预测：依技术划分
    • 基因敲除
    • 基因敲入
    • 基因静默
    • 基因编辑
  • 市场规模及预测：依应用领域划分
    • 临床应用
    • 研究用途
    • 农业应用
    • 工业应用
  • 市场规模及预测：依最终用户划分
    • 生技公司
    • 製药公司
    • 学术机构
    • 研究所
  • 市场规模及预测：依组件划分
    • DNA模板
    • 引导RNA
    • 核酸酶
    • 修復模板
  • 市场规模及预测：依製程划分
    • In vivo
    • 体外
    • Ex Vivo
  • 市场规模及预测：依功能划分
    • 基因破坏
    • 基因校正
    • 基因转移
  • 市场规模及预测：依设备划分
    • 序列器
    • 转染装置
    • 细胞分选装置

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Editas Medicine
  • Intellia Therapeutics
  • CRISPR Therapeutics
  • Beam Therapeutics
  • Sangamo Therapeutics
  • Precision Bio Sciences
  • Caribou Biosciences
  • Cellectis
  • Gen Edit
  • Poseida Therapeutics
  • Horizon Discovery
  • Inscripta
  • Synthego
  • Mammoth Biosciences
  • e Genesis
  • Ori Gene Technologies
  • Agenovir Corporation
  • Recombinetics
  • Telesis Bio
  • Pairwise

第九章：关于我们

简介目录
Product Code: GIS32780

Genomic Editing Tools Market is anticipated to expand from $10.9 billion in 2024 to $51.3 billion by 2034, growing at a CAGR of approximately 20%. The Genomic Editing Tools Market encompasses technologies enabling precise DNA modification, including CRISPR, TALENs, and ZFNs. These tools facilitate advancements in medicine, agriculture, and biotechnology by enabling gene therapy, crop enhancement, and synthetic biology. The market is driven by rising demand for personalized medicine, increased R&D investments, and regulatory advancements. Innovations focus on improving accuracy, efficiency, and ethical considerations, underscoring the transformative potential of genomic editing in addressing global health and food security challenges.

The Genomic Editing Tools Market is experiencing robust growth, propelled by advancements in biotechnology and increasing applications in healthcare. The CRISPR segment is the top-performing sub-segment, owing to its precision and efficiency in gene editing. TALENs and ZFNs follow, offering alternative solutions for complex genetic modifications. The therapeutics application segment leads, driven by innovations in personalized medicine and gene therapies targeting rare diseases. Agricultural applications are the second highest-performing segment, reflecting the growing need for enhanced crop traits and sustainable farming practices. Research and academic institutions are significant contributors, as they continue to explore new genomic editing possibilities. The development of novel delivery systems is further enhancing market dynamics, enabling targeted and efficient gene editing. Ethical considerations and regulatory frameworks are shaping the market landscape, emphasizing the need for responsible innovation. The integration of AI and bioinformatics is poised to revolutionize the genomic editing field, unlocking new opportunities for growth.

Market Segmentation
TypeCRISPR, TALENs, Zinc Finger Nucleases, Meganucleases
ProductReagents, Kits, Instruments, Software
ServicesCustom Services, Consultation Services, Validation Services
TechnologyGene Knockout, Gene Knock-in, Gene Silencing, Gene Editing
ApplicationClinical Applications, Research Applications, Agricultural Applications, Industrial Applications
End UserBiotechnology Companies, Pharmaceutical Companies, Academic Institutions, Research Laboratories
ComponentDNA Templates, Guide RNA, Nucleases, Repair Templates
ProcessIn Vivo, In Vitro, Ex Vivo
FunctionalityGene Disruption, Gene Correction, Gene Insertion
EquipmentSequencers, Transfection Equipment, Cell Sorters

The Genomic Editing Tools Market is characterized by a dynamic competitive landscape with significant market share held by leading biotechnology firms. Pricing strategies are evolving, reflecting the introduction of innovative products and the increasing demand for precision medicine. New product launches are frequent, highlighting the rapid advancements in CRISPR technology and other gene-editing platforms. The market is witnessing a shift towards more cost-effective and efficient solutions, driven by technological advancements and increased research funding. Competition within the genomic editing tools sector is intense, with several key players striving for dominance through strategic alliances and acquisitions. Regulatory frameworks, particularly in North America and Europe, play a crucial role in shaping market dynamics. These regulations ensure ethical standards and safety, influencing the pace of technological adoption. The market is poised for growth, propelled by the rising prevalence of genetic disorders and the expanding applications of genomic editing in agriculture and therapeutics. Continuous innovation and regulatory compliance remain pivotal in maintaining competitive advantage and fostering market expansion.

Geographical Overview:

The genomic editing tools market is witnessing a dynamic expansion across various regions, each presenting unique growth opportunities. North America dominates the market, driven by substantial investments in biotechnology and a robust research ecosystem. The presence of leading biotech firms and academic institutions further enhances the region's market position. Europe is emerging as a significant player, bolstered by strong regulatory frameworks and public funding for genomic research. The region's focus on precision medicine and personalized healthcare propels market growth. In Asia Pacific, the market is rapidly expanding, fueled by increasing government support and growing biotechnology industries. Countries like China and India are at the forefront, harnessing genomic editing technologies to advance healthcare solutions. Latin America and the Middle East & Africa are nascent markets with promising potential. Brazil is investing in biotech innovations, while countries in the Middle East are recognizing the strategic importance of genomic editing in advancing medical research and healthcare outcomes.

Global tariffs and geopolitical tensions are profoundly impacting the Genomic Editing Tools Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are enhancing domestic R&D to mitigate reliance on imported genomic technologies, while China accelerates its focus on self-sufficiency amid export restrictions. Taiwan, pivotal in biotech manufacturing, navigates US-China tensions with strategic alliances. The parent market is experiencing robust growth, driven by advances in CRISPR and gene therapy. By 2035, the market is poised for exponential expansion, contingent on geopolitical stability and innovation in supply chains. Middle Eastern conflicts further complicate supply chains, influencing energy prices and operational costs, thereby necessitating resilient strategies to ensure market sustainability and growth.

Key Trends and Drivers:

The genomic editing tools market is experiencing robust growth, fueled by advancements in CRISPR technology and increasing research investments. Key trends include the integration of AI and machine learning for enhanced precision and efficiency in gene editing. This technological synergy is streamlining processes and reducing timeframes for research and development. Furthermore, the rise of personalized medicine is driving demand for genomic editing tools, as healthcare shifts towards tailored therapeutic solutions. The agricultural sector is also a significant driver, with genome editing tools being utilized to develop crops with improved yield and resistance to environmental stressors. This trend is particularly pronounced in regions facing climate change challenges. Additionally, regulatory support and government funding for biotechnological research are bolstering market growth. Opportunities abound in emerging markets where biotechnology infrastructure is rapidly developing, attracting investments and fostering innovation. Moreover, ethical and safety considerations are shaping the market landscape, prompting companies to invest in developing safer and more precise editing techniques. As public awareness and acceptance grow, the potential applications of genomic editing tools are expanding, encompassing a wide range of industries beyond healthcare and agriculture. The market is poised for sustained growth, driven by continued technological advancements and increasing interdisciplinary collaborations.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 CRISPR
    • 4.1.2 TALENs
    • 4.1.3 Zinc Finger Nucleases
    • 4.1.4 Meganucleases
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Kits
    • 4.2.3 Instruments
    • 4.2.4 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Services
    • 4.3.2 Consultation Services
    • 4.3.3 Validation Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Gene Knockout
    • 4.4.2 Gene Knock-in
    • 4.4.3 Gene Silencing
    • 4.4.4 Gene Editing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Applications
    • 4.5.2 Research Applications
    • 4.5.3 Agricultural Applications
    • 4.5.4 Industrial Applications
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Biotechnology Companies
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Academic Institutions
    • 4.6.4 Research Laboratories
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 DNA Templates
    • 4.7.2 Guide RNA
    • 4.7.3 Nucleases
    • 4.7.4 Repair Templates
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 In Vivo
    • 4.8.2 In Vitro
    • 4.8.3 Ex Vivo
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Gene Disruption
    • 4.9.2 Gene Correction
    • 4.9.3 Gene Insertion
  • 4.10 Market Size & Forecast by Equipment (2020-2035)
    • 4.10.1 Sequencers
    • 4.10.2 Transfection Equipment
    • 4.10.3 Cell Sorters

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Functionality
      • 5.2.1.10 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Functionality
      • 5.2.2.10 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Functionality
      • 5.2.3.10 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Functionality
      • 5.3.1.10 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Functionality
      • 5.3.2.10 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Functionality
      • 5.3.3.10 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Functionality
      • 5.4.1.10 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Functionality
      • 5.4.2.10 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Functionality
      • 5.4.3.10 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Functionality
      • 5.4.4.10 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Functionality
      • 5.4.5.10 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Functionality
      • 5.4.6.10 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Functionality
      • 5.4.7.10 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Functionality
      • 5.5.1.10 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Functionality
      • 5.5.2.10 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Functionality
      • 5.5.3.10 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Functionality
      • 5.5.4.10 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Functionality
      • 5.5.5.10 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Functionality
      • 5.5.6.10 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Functionality
      • 5.6.1.10 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Functionality
      • 5.6.2.10 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Functionality
      • 5.6.3.10 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Functionality
      • 5.6.4.10 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Functionality
      • 5.6.5.10 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Editas Medicine
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Intellia Therapeutics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CRISPR Therapeutics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Beam Therapeutics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Sangamo Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Precision Bio Sciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Caribou Biosciences
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cellectis
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Gen Edit
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Poseida Therapeutics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Horizon Discovery
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Inscripta
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Synthego
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Mammoth Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 e Genesis
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Ori Gene Technologies
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Agenovir Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Recombinetics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Telesis Bio
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Pairwise
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us